Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aglaia Chalkia

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2024
Avacopan for ANCA-associated vasculitis with hypoxic pulmonary haemorrhageAglaia Chalkia, Oliver Flossmann, Rachel Jones, et al.
Renal Failure|August 14, 2020
Hypocomplementemia is associated with more severe renal disease and worse renal outcomes in patients with ANCA-associated vasculitis: a retrospective cohort studyAglaia Chalkia, Konstantinos Thomas, Panagiota Giannou, et al.
Rheumatology (Oxford, England)|May 12, 2023
Health-related quality of life in patients with ANCA vasculitides compared to rheumatoid arthritis: a cross-sectional comparative studyAlexandros Panagiotopoulos, Konstantinos Thomas, Evangelia Argyriou, et al.
Arthritis Research & Therapy|March 20, 2021
Serious infections in ANCA-associated vasculitides in the biologic era: real-life data from a multicenter cohort of 162 patientsKonstantinos Thomas, Evangelia Argyriou, Noemin Kapsala, et al.
Frontiers in Immunology|April 13, 2023
The genomic landscape of ANCA-associated vasculitis: Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosusAggelos Banos, Konstantinos Thomas, Panagiotis Garantziotis, et al.
Journal of Clinical Medicine|June 27, 2024
Urine Nephrin and Podocalyxin Reflecting Podocyte Damage and Severity of Kidney Disease in Various Glomerular Diseases-A Cross-Sectional StudyPanagiota Giannou, Harikleia Gakiopoulou, Emelina Stambolliu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 31, 2026
Extrarenal Disease in ANCA-Associated Vasculitis: Challenges and Evolving Therapeutic Strategies on behalf of the Immunonephrology Working Group (IWG) of the ERAAglaia Chalkia, Eleni Frangou, Annette Bruchfeld, et al.
Rheumatology (Oxford, England)|August 7, 2024
Relapses and serious adverse events during rituximab maintenance therapy in ANCA-associated vasculitis: a multicentre retrospective studyChrysoula G Gialouri, Aglaia Chalkia, Christos Koutsianas, et al.
RMD Open|June 24, 2026
No benefit of adding glucocorticoids to maintenance treatment in reducing the risk of major relapses in ANCA-associated vasculitis: real life data from a longitudinal cohort studyKaterina Chavatza, Chrysoula G Gialouri, Konstantinos Drougkas, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2026
Interstitial Lung Disease in ANCA-Associated Vasculitis: A European Multicentre StudyAglaia Chalkia, Marusa Kotnik, Timothy J Sadler, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 25, 2024
Avacopan for ANCA-associated vasculitis with hypoxic pulmonary haemorrhageAglaia Chalkia, Oliver Flossmann, Rachel Jones, et al.
Renal Failure|August 14, 2020
Hypocomplementemia is associated with more severe renal disease and worse renal outcomes in patients with ANCA-associated vasculitis: a retrospective cohort studyAglaia Chalkia, Konstantinos Thomas, Panagiota Giannou, et al.
Rheumatology (Oxford, England)|May 12, 2023
Health-related quality of life in patients with ANCA vasculitides compared to rheumatoid arthritis: a cross-sectional comparative studyAlexandros Panagiotopoulos, Konstantinos Thomas, Evangelia Argyriou, et al.
Arthritis Research & Therapy|March 20, 2021
Serious infections in ANCA-associated vasculitides in the biologic era: real-life data from a multicenter cohort of 162 patientsKonstantinos Thomas, Evangelia Argyriou, Noemin Kapsala, et al.
Frontiers in Immunology|April 13, 2023
The genomic landscape of ANCA-associated vasculitis: Distinct transcriptional signatures, molecular endotypes and comparison with systemic lupus erythematosusAggelos Banos, Konstantinos Thomas, Panagiotis Garantziotis, et al.
Journal of Clinical Medicine|June 27, 2024
Urine Nephrin and Podocalyxin Reflecting Podocyte Damage and Severity of Kidney Disease in Various Glomerular Diseases-A Cross-Sectional StudyPanagiota Giannou, Harikleia Gakiopoulou, Emelina Stambolliu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 31, 2026
Extrarenal Disease in ANCA-Associated Vasculitis: Challenges and Evolving Therapeutic Strategies on behalf of the Immunonephrology Working Group (IWG) of the ERAAglaia Chalkia, Eleni Frangou, Annette Bruchfeld, et al.
Rheumatology (Oxford, England)|August 7, 2024
Relapses and serious adverse events during rituximab maintenance therapy in ANCA-associated vasculitis: a multicentre retrospective studyChrysoula G Gialouri, Aglaia Chalkia, Christos Koutsianas, et al.
RMD Open|June 24, 2026
No benefit of adding glucocorticoids to maintenance treatment in reducing the risk of major relapses in ANCA-associated vasculitis: real life data from a longitudinal cohort studyKaterina Chavatza, Chrysoula G Gialouri, Konstantinos Drougkas, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2026
Interstitial Lung Disease in ANCA-Associated Vasculitis: A European Multicentre StudyAglaia Chalkia, Marusa Kotnik, Timothy J Sadler, et al.
Pageof 3